RxDoctor Payments Data

Stefan Szczerba, MD

Plastic and Reconstructive Surgery · Chicago, ILNPI 1881685873

Payments from drug & device makers

What this record shows

This record is dominated by gifts: $21,716 of the $28,969 with a category attached, or 75.0%. AbbVie accounts for 81.7% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $22,129 and has fallen 96.2% since, to $852 in 2025. Among plastic and reconstructive surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,969in general payments, 2019–2025

Across 213 payments — averaging $136.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$24K
  • Mentor Worldwide LLC$1K
  • Bard Peripheral Vascular, Inc.$828
  • Axogen$550
  • Davol Inc.$450
  • Motiva USA, LLC$336
  • plus $2K from 20 others

What the payments were for

  • Consulting fees$6402%
  • Food & beverage$6,61323%
  • Gifts$21,71675%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,969 in reported general payments places this provider in the 90th percentile of 126 plastic and reconstructive surgery providers in Illinois.

See all plastic and reconstructive surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$77,818
Medicare patients
59
Services billed
276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin57$490
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$339
Cyclobenzaprine Hcl47$257
Ondansetron OdtOndansetron50$183
Clindamycin Hcl15$122

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →